Among people taking insulin, share paying more than an average of $35 a month per insulin product, by health insurance market, plan metal, and cost-sharing reductions (CSRs), 2018
Individual market (direct purchase)
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
Bronze
52%
Silver
(no CSR)
49%
Silver
(73% CSR)
39%
Silver
(87% CSR)
17%
Silver
(94% CSR)
6%
Gold
40%
Platinum
4%
Small group market
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
Bronze
53%
Silver
41%
Gold
29%
Platinum
10%
Large employer market
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
Large employer market
19%
